Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors

Published: Friday, February 14, 2014
Last Updated: Friday, February 14, 2014
Bookmark and Share
Presents validation data for improving media screening and process optimization.

TAP Biosystems has announced that it will be co-presenting a new bioprocess webinar with Irvine Scientific, a major producer of cell culture media, on Wednesday March 12th 2014 at 9 am PST / 12 noon EST / 4 pm GMT.

The live event will detail how to use ambr™ automated micro bioreactor system in alternative semi-continuous modes to mimic perfusion cultures and how this can be used to save time with process optimization and media screening.

Bioprocessing experts, Tom Fletcher, R&D Director at Irvine Scientific and Dr Don Traul, Product Specialist at TAP Biosystems, will present technical data on the use of the ambr 10 - 15ml micro bioreactor system, as a small scale perfusion culture mimic.

To access the webinar, scientists can register at:

During the webinar, Dr Traul will describe how the ambr system has been utilized as a semi-continuous chemostat model, present field data validating the scalability of the ambr system for continuous culture, and discuss associated DoE applications for media development.

Tom Fletcher will be presenting his use of the ambr system in an alternative semi-continuous mode and will describe the productivity benefits of using ambr to screen a range of candidate media formulations.

Dr Don Traul, TAP Biosystems’ ambr Product Specialist commented: "To date there has been a lack of good scale-down models of large-scale perfusion culture, which has prevented the widespread adoption of this technique as a method for increasing protein yields in biologics production.”

Traul added: “Perfusion culture is a good option for production of unstable or minimally expressing proteins or antibodies and I am pleased to be hosting a webinar alongside Tom Fletcher in which we’ll show proof-of-concept data for use of ambr as a scale down perfusion culture mimic. This will demonstrate how ambr may benefit scientists looking for a strategy to save valuable time with media and process development and will provide them with information on how to rapidly scale up an optimum perfusion culture process for improving production of difficult to manufacture biologics.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
Monday, January 20, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
Study Finds Key Regulator in Pulmonary Fibrosis
Researchers identify an enzyme that could open the way to therpies for chronic fatal lung disease.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Curcumin Shows Promise as Cancer Treatment
When delivered at the correct circadian phase, curcumin demonstrates sustained toxicity in cancer cells and should be considered for use in patient care.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
Using Stem Cells to Grow a 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
Puttng Cells Through Their Paces
An obstacle course for human lung cells could be the answer for better testing the effectiveness of potential new drugs.
Inherited Heart Condition Breakthrough
Using stem cells, scientists have created a specific heart condition model, yeilding insights into unexpected disease mechanisms.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos